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Cytoskeleton is considered to be the cellular scaffolding or skeleton. 
Cytoskeleton is contained, as 
all other organelles, within the 
cytoplasm of all eucaryotic 
cells (Fig. 1). Recent research 
carried out with electron 
microscopy on some 
eubacteria has demonstrated 
that cytoskeleton can be 
present in prokaryotic cells too 
(Mayer, 2006). Cytoskeleton is 
a dynamic fibrillary structure 
that is essential to keep and 
determine any cellular shape 
changes. It is well known that cytoskeleton make possible some cell 
motion (by characteristic cellular structures such as flagella and 
cilia), and plays a crucial role both in intra-cellular transport such as 
in the movement of vesicles, organelles and cellular division. 
Cytoskeleton is a bone-like structure floating around/within the 
cytoplasm essentially composed by three main filaments: 
microfilaments or actin filaments, intermediate filaments (IFs) and 
microtubules. Every cytoskeletal filaments are protein structures 
having the capability, except intermediate filaments, to rapidly 
polymerize and depolymerize. Accessory proteins bound the 
filaments and regulate their assembly. 
Fig. 1. The eucaryotic cytoskeleton. 
Bovine pulmonary artery endothelial 
cells: actin filaments are in red (Texas 
Red-Phalloidin staining), microtubules 
are in green (Bodipy FL goat anti-mouse 







Microfilaments are the thinnest filamentous cytoskeletal proteins, 
measuring approximately 7 nm 
in diameter (Fig. 2). 
The single subunits of actin are 
known as globular actin (G-
actin) while the whole 
filamentous polymer that is 




G-actin is a globular structural, 
42-47 kDa protein found in 
many eucaryotic organisms, with concentrations of over 100µM. It is 
also one of the most highly preserved proteins, differing by no more 
than 5% in species as diverse as algae and humans.  
 
Microfilaments assembly 
Actin is the monomeric subunit of microfilaments. Microfilaments 
have a polar structure like the microtubules since they have a fast 
growing plus end (also known as barbed end) and a slow growing 
minus end (also known as pointed end). The terms barbed and 
pointed come from the arrow-like appearance of the proteic structure 
as it has been seen in Electron Micrographs. Filaments elongate 
approximately 10 times faster at the plus end than at the minus end. 
Fig. 2. Actin cytoskeleton. Mouse 





When the polymerization rate at the plus end equals the 
depolymerization at the minus end the result is a tread-milling effect 
where the filaments move without changing its overall length.  
Nucleation is the process of actin polymerization and it starts with 
the association of three G-actin monomers into a trimer. ATP-actin 
binds the plus (+) end then ATP (adenosine triphoshate) is 
hydrolyzed (half time 2 seconds) and the inorganic phosphate 
released (half time 6 minuts) (Pollard et al., 2004). ADP-actin 
dissociates from the minus end so that consequent increase in ADP 
stimulates the exchange of bound ADP-ATP leading to more      
ATP-actin units. The rapid turn-over is important for cell movement.  
Three proteins which are regulated by cell signaling mechanisms, 
work for microfilaments’ functionality. CapZ (known as end capping 
proteins), prevents the addition or loss of monomers at the filaments 
when actin turn-over is unfavorable like in the muscle apparatus. 
Cofilin binds to ADP-actin units and promotes their dissociation 
from the minus end preventing their reassembly as well. On the other 
hand, profilin reverses cofilin effect by stimulating the exchange of 
bound ADP for ATP. Finally, the Arp2/3 complex nucleates new 
actin filaments while bound to existing filaments and create the 
branched network. 
 
Microfilaments organization and functions 
Microfilaments are an ubiquitary contractor organ not only involved 
in some cell-to-cell or cell-to-matrix junctions and transduction of 
signals but also engaged in keeping cellular shape or forming 
cytoplasmatic protuberances such as pseudopodia and microvilli. 
Moreover, microfilaments are crucial for cell movement 
(cytokinesis) and, along with myosin, muscular contraction.  
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Actin filaments are gathered in two types of structures: network and 
bundles with the characteristic features of a double-stranded helix. 
Networks are constituted by actin along with many actin-binding 
proteins (such as the Arp2/3 complex and filamin) that are 
characteristically concentrated at the cortical regions of the cells. 
Recently, it has been proved that actin network is involved in some 
cellular defensive mechanisms serving as barriers for molecular 
diffusion within the plasmatic membrane. In non-muscle actin 
bundles, the filaments are held together:  they are kept parallel each 
other by actin-bundling proteins and/or cationic species. Bundles 





Intermediate filaments (IFs) are 
heterogeneous cytoskeletal 
structures formed by members of a 
family of related proteins (Fig. 3). 
IFs have a diameter between that of 
microfilaments and microtubules 
(7-11nm); IFs differ from 
microfilaments and microtubules 
not only for their chemical 
properties but also because they are 
very stable structures, formed by 
fibrotic subunit proteins. Most types of IFs are located in the cytosol 
between the nuclear envelope and the cell surface membrane.  
Fig. 3. Intermediate filaments in 
epithelial cells (MDCK). Keratin 
filaments which are in red (Texas Red-
Phalloidin staining), are concentrated 
around the edge of the cells, whereas 
DNA is visualized in green (Methyl 





The domain structure of IFs molecules is conserved. Proteins have a 
typical non-α-helical (globular) domain at the N- and C-termini 
which surrounds the α-helical rod domain. The essential IFs building 
block is a parallel, in register dimer that is constituted through the 
interaction of the rod domain forming a coiled tail. Cytoplasmatic 
IFs assemble into non-polar unit-length filaments that then gather 
into longer structures. The characteristic anti-parallel orientation of 
the fibrotic subunits means that, unlike microtubules and 
microfilaments have a plus and a minus end, IFs lack any polarity 
and do not undergo tread-milling. New evidences have showed that 
IFs can be  also dynamic and motile elements of the cytoskeleton 
(Helfand et al., 2004). 
 
Types of intermediate filaments 
There are about 70 different genes encoding for various intermediate 
filament proteins that are subcategorized into six types based on 
similarities in amino acidic sequence and protein structure. 
 
Types I and II (Acidic and Basic Keratins)  
They are an heterogenous class of IFs which constitute type I (acidic) 
and type II (basic) IFs proteins. They are further divided in two 
groups: 
• Epithelial keratins (about 20): typical in epithelial cells; 
• Trichocytes keratins (about 13): hair keratins which make 
up hair, nails, horns and reptilian scales. Acidic and basic keratins 
bind each other forming acidic-basic heterodimers that associate 





Four proteins which may form homo- or heteropolymeric proteins 
are classified as type III: 
• Desmin: a structural component of the sarcomeres in muscle 
cells; 
• GFAP (glial fibrillary, acidic protein): found in astrocytes 
and glia cells; 
• Peripherin: found in periheral nerve; 
• Vimentin: the most widely diffused of all IFs proteins which 
can be found in fibroblasts, leukocytes, blood vessels and endothelial 
cells. Vimentin provides for the cellular membrane and keeps some 
organelles in a fixed place within the cytoplasm.   
 
Type IV 
IFs that are exclusively present in the nervous system: 
•          Internexin: the major component of the IFs network in small 
interneurons and cerebellar granule cells; 
• Nestin: expressed mostly in the nervous cells. They are 
implicated in the radial growth of the axon;  
•     Neurofilaments: found in high concentrations along the 
axon of vertebrate neurons; 
•     Synemin: originally found at the Z-band of avian and rodent 
skeletal and cardiac muscles. It occurs together with nestin and 
vimentin in glial progenitors during the early differentiation of the 
mouse central nervous system; 
• Syncoilin: found at the neuromuscular junction, 




Type V  
Nuclear lamins. 







General features  
Microtubules are long filamentous, tube-shaped protein polymers 
present in all eukaryotic cells. Microtubules are crucial in some 
cellular activities such as morphogenesis, cell mobility, cell 
signaling and organelles transport. In details, microtubules 
rearrange during cell division to form the mitotic spindle, which is 
fundamental not only for the segregation and the replication of 
sister cromatids, but also for the orientation of the cell cleavage 
plane. Moreover, microtubules are the most prominent constituent 
of the composite and extremely organized axonemal structure of 
cilia and flagella. In addition, microtubules contribute in the 
generation of cell polarity and they work, with several motor 
proteins, as tracks along which organelles and/or vesicles are 
transported through the cell. 
The great variety of microtubule functions comes from the 
amazing structural flexibility of microtubule organization 
depending, in a large extent, on their remarkable biochemical and 
functional properties. Microtubular arrays in eukaryotic cells are 
dynamic, able to assembly (polymerize), disassembly 
(depolymerize) and rearrange within few seconds or minutes. This 
typical property is called microtubular dynamics. It is well known 
that microtubular dynamics are based on intrinsic dynamic 
properties of the tubulin polymers themselves which are regulated 
by the biochemical features of the main microtubule building 
block, the tubulin α-β heterodimer.  
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Among tubulin biochemical attitudes, there is the tubulin intrinsic 
capability to interact in vivo and in vitro with a great number of 
other proteins such as small molecules, nucleotides or drugs that 
can modify the physiological characteristic of the whole polymer.  
Finally, it is of interest considering that tubulin is a GTPase as 
well. The phenomenon of GTP hydrolysis occurs during tubulin 
polymerization and is essential for the microtubular functional 
properties.  
 
Microtubules and tubulin 
structure 
 
Microtubules are composed 
of α-tubulin and β-tubulin 
heterodimers. α and 
β tubulin monomers are 
proteins of about 450 amino 
acids and each monomers 
have a molecular mass of 
about 50,000Da (Fig. 4). 
Tubulins are ubiquitous and, 
in eukaryotic organisms, 
several genes are known 
encoding for six α-tubulin 
and seven β-tubulin isotypes. Three α-tubulin isotypes (1, 2 and 4) 
and five β-tubulins (I, II, III, IVa and IVb) are expressed in the 
brain (Luduena et al., 1998; Lee et al., 1990; Redeker et al., 1998) 
(Table 1). 
 
Fig. 4. Three-dimensional model of  
tubulin. The protein is a dimer consisting 
of two monomers that are almost 
identical in structure. Each monomer is 
formed by a core of two beta sheets (blue 
and green) surrounded by helices, and 





       
       Table 1. Overview of the various tubulin isoforms (from Bianchi et al., 2005). 
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α-tubulin and β-tubulin heterodimers arrange linearly into 
protofilaments that associate laterally forming microtubular structures 
with an outer diameter of 25 nm (Fig. 5).  
         
 
Fig. 5. α-β tubulin heterodimers arrange linearly into protofilaments (From 
Westermann and Weber, 2003). 
 
Different experimental conditions in vitro may vary the number of 
protofilaments of microtubules between 10 and 15, whereas they are 
13 in physiological conditions in vivo. The organization of α- and α-β 
tubulin heterodimers in the microtubular structure is polarized, and 
this feature determines important structural and kinetic differences at 
the microtubule ends. α and β-tubulin heterodimers are arranged in a 
typical head-tail configuration in which they are polarized with a 
faster elongating end, named plus, exposing β subunits, and a slower 
elongating minus which show the alpha subunit in vivo. The minus 
end of the microtubules is associated with the centrosome and is 
localized close to the center of the cell, while the plus end is 
peripheral (Valiron et al., 2002) (Fig. 6).  
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Fig. 6. α and β-tubulin are arranged in a head-tail configuration in which they are 
polarized with a faster elongating end, named plus, exposing β subunits, and a 




Microtubule assembly proceeds in three phases: nucleation, 
elongation and steady-state. 
Nucleation, also known as microtubules aggregation, is the phase of 
microtubular assembly in which a small cluster of α and β tubulin 
monomers aggregate to form a short microtubule nucleus arranged to 
initiate polymerization properly. The nucleation may give in a variety 
of conditions. Temperature is a fundamental factor; indeed, tubulin 
aggregation generally occurs at 30°-37°C, whereas lower temperature 
do not arise microtubules aggregation anymore. Another fundamental 
condition is microtubule incorporation as a complex with GTP whose 
energy input from hydrolysis works for tubulin dynamics. Nucleation 
is followed by the so-called elongation phase during which α-β dimers 
are added to the end of each microtubular structure just formed.  
Steady state is the last phase of tubulin assembly. In vitro studies have 
probed that a determined proportion of tubulin is in the polymerized 
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form, whereas another tubulin pool stands soluble (free proportion). 
Fascinatingly, the amount of soluble tubulin, which is in form of 
dimers during the steady state, varies with buffer conditions and this 
amount constitutes the critical concentration for microtubule 
assembly. Steady state is characterized by a constant GTP hydrolysis. 
Consumption of energy is necessary for maintenance of the steady 
state of microtubules since microtubules use energy to continuously 
provide molecular exchanges between α-β constitutive subunits and 
the tubulin molecules of the soluble pool (Margolis and Wilson, 
1981). Several studies have clarified the mechanisms that are involved 
in such a continuous exchange. The first is known as tread-milling. 
Tread-milling depends on a typical property of microtubular ends at 
the steady state (or pause): the plus end continuously incorporates 
new tubulin dimers, while at the same time the minus end looses 
them. The energy required for such a dynamic process comes from 
GTP hydrolysis but the precise mechanism that joins the functional 
asymmetry of the tubulin ends is still unknown. When tubulin ends 
are in a fixed position, tread-milling results in a sort of microtubular 
migration that reproduces the propagation of a wave of tubulin 
assembly and disassembly. By contrast, when microtubular ends are 
kept in a stationary position, tread-milling generates an apparent flux 
that travels from the minus to the plus end (Margolis and Wilson, 
1981) (Fig. 7). 
The second mechanism is known as dynamic instability. Some models 
of study showed that, while a population of microtubules exhibits a 
steady state, an individual microtubule persists in a slow phase of  














equilibrium length. In details, the phase between slow assembly and 
fast disassembly is called catastrophe and the phase between 
disassembly and assembly is referred to as rescue (Fig. 7). 
Taking into account these notions, microtubular dynamics are, by 
definitions, the intrinsic capability of microtubular polymers to 
rapidly change its biochemical and functional properties as 
consequence of overall environmental conditions. Polymerized 
microtubules are intrinsically labile but at the steady state, the whole 
microtubular system remains out of equilibrium. Events like 
temperature fall below 10°-15°C readily depolymerize microtubules. 
Moreover, other events such as removal of GTP, dilution of 
microtubule suspension with consequent decrease in soluble tubulin 
concentration, can induce tubulin disassembly. In addition, specific 
drug as colchicine, vinblastine or nocodazole can easily trigger 
tubulin depolymerization with different mechanisms of action. In 
details, colchicine and vinblastine perturb tubulin assembly into 
microtubules consequently inducing tubulin depolymerization. 
Naconazole sequesters tubulin dimers in inactive form that, 
decreasing the soluble pool of tubulin below the critical concentration, 
Fig. 7. Tread-milling & dynamic instability (From http://www.ijpb.versailles.inra). 
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induces microtubules depolymerization (Fig. 8).  
 
 
Fig. 8. Tubulin pathways: perturbation of tubulin dynamics via specific MAPs 
such as Tau or traditional anticancer agents may lead to mitosis block and, by 
consequence, cell death (From http://merckbiosciences.com). 
 
Microtubules dynamics in vivo and in vitro 
In vivo studies on microtubule dynamics have revealed some 
extensive similarities with microtubule dynamics in vitro. 
Microtubule dynamics and dynamic instability (the main mechanism 
of microtubules turnover) has been clearly demonstrated in eukaryotic 
cells. However, differences in the rate of microtubular assembly (10-
15% higher than in vitro microtubules formed by pure tubulin) and 
the control of the microtubular polymer by cell effectors has been 
found (Cassimeris, 1993). It is well known that cell regulation 
influences both microtubule nucleation and assembly. Nucleation in 
vivo is only provided by the centrosome (also called microtubule-
organizing center) and in most cells, the minus ends of microtubules 
are linked to the centrosome. Moreover, microtubule dynamics in vivo 
are regulated by many microtubule-associated proteins (MAPs) that 
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are usually classified in two main groups: proteins that stabilize and 
proteins that destabilize microtubules. Recent studies have also 
highlighted other function of MAPs depending on cellular context, 
especially with regard to regulation of the mitotic spindle, assembly, 
and overall microtubular organization and dynamicity in vivo. MAPs 
have been also discovered to interact with actin, intermediate 
filaments and to modulate microtubule dynamics as motor proteins. 
 
Microtubules-stabilizing proteins  
Microtubule-stabilizing proteins promote tubulin assembly and 
stabilize microtubules. Members of this family include the proteins 
tau, MAP2 (present in the axon and dendrites, respectively), and 
MAP4. 
A new group of MAPs inducing much higher microtubular stability 
has been recently identified. This group includes Lis1(Lissencephaly 
Isolated Type 1), doublecortin, BPAG1 (Bullous Pemphigoid Antigen 
1) and STOP (Stable Tubulin Only Peptide) proteins. Lis1 is 
distributed along microtubules, not only in neuronal cells but also in 
several cell phenotypes. Lis1 interacts with the microtubule motor 
dynein. In details, production of dynein increases retrograde 
movement of cytoplasmic dynein and leads to peripheral 
accumulation of microtubules. These findings suggest that the amount 
of Lis1 may stimulate specific dynein functions in neuronal migration 
and axon growth (Smith et al., 2000). Doublecortin is expressed in 
migrating and differentiating neurons and it can be associated in vitro 
and in vivo with microtubules acting as microtubular stabilizer. 
BPGA1 has the property to physically link actin, intermediate 
filaments and microtubular networks. BPGA1 can bind and stabilize 
microtubules in vitro so that microtubules become sensitive to various 
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depolymerizing agents, including cold. Cold stability can also be due 
to microtubules association with different variants of STOP that are 
typical calmodulin-regulated proteins. In spite of STOP come from a 
single gene, variants have different start genes of transcription and are 
expressed in many tissues at diverse stages of development. In 
neuronal cells, STOP proteins seem to be associated with 
microtubules: they are the major factors responsible for the slow 
turnover of neuronal microtubules and apparently required for 
neuronal differentiation. In addition, STOP proteins can be associated 
with microtubules in the mitotic spindle and such association appears 
to be fundamental for the progress of the mitotic process.  
Though several proteins have been identified as microtubule-
stabilizing proteins, their mechanisms of action are not well known 
yet. Op18/stathmin is a small ubiquitous protein which has been 
shown to destabilize microtubules by increasing the catastrophe 
frequency and regulating microtubules levels both in vivo and in vitro 
(Belmont and Mitchison, 1996). Two mechanisms involved in the 
Op18/stathmin mechanism of action have been postulated.  
Op18/stathmin has been hypothesized to sequester tubulins, lowering 
the total soluble amount of tubulin available for polimerization. 
Furthermore, Op18/stathmin may act directly on microtubules like a 
catastrophe-promoting factor. Another class of microtubule-
stabilizing proteins is formed by the members belonging to the super-
family of kinesin-related microtubules motor proteins. XKCM 
(Xenopus Kinesin-Related Protein) is a kinesin-related motor protein 
with the capability to inhibit mitotic spindle in vitro and to determine 
microtubule catastrophe in vivo. Heat-shock proteins (HSP27, HSP70 
and HSP9) have been seen inhibiting microtubule formation in vitro at 
high concentrations as well. Finally, a small acidic polypeptide, 
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MINUS (Microtubule Nucleation Suppressor), biochemically purified 
from cultured cell lines and bovine brain, was ascertained to block 
microtubule nucleation in vitro in centrosome presence or absence.  
Post-translational modifications 
Microtubules heterogeneity is determined by several post-translational 
modifications such as tyrosination/detyrosination, acetylation, 
polyglycilation, polyglutamylation, phosphorylation and 
palmitoylation (Westermann and Weber, 2003). These modifications 
usually occur at the carboxy-terminal domain of the α-β heterodimer, 
in correspondence of the outer surface of the microtubule where it can 
interact with other proteins (Westermann and Weber, 2003). 
Tyrosination/detyrosination: the tyrosination cycle 
Tyrosination is a post-translational modification consisting in the 
addition of a carboxy-terminal tyrosine to most α-tubulins (Fig. 9).  
The first step of this modification is the removal of the carboxy-
terminal tyrosine (detyrosination) by a tubulin tyrosine 
carboxipeptidase (TTCP). This post-translational modification occurs 
after microtubule assembly since the TTCP prefers polymers. 
(Argarana et al., 1978). The tyrosinated tubulin displays a carboxy-
terminal glutamic acid that is usually referred as Glu-tubulin. In 
addition, losing Glu-tubulin the penultimate glutamate residue 
through the enzymatic action of a still unknown peptidase, ∆2 tubulin  
can be generated as well (Paturle-Lafanechère et al., 1991). 
Interestingly, ∆2 
 
cannot be a substrate for the tubulin tyrosine ligase 
(TTL) and does not take part to the tyrosinated cycle (Paturle-
Lafanechère et al., 1991). ∆2 represents the final stage of α-tubulin 
 26 
 
 maturation, it constitutes a considerable proportion of brain tubulin 
and it is known as a marker of very long-lived, stable microtubules 
(Paturle-Lafanechère et al., 1994).  
An ATP-dependent reaction catalized by the activity of TTL can 
restore the carboxy-terminal tyrosine (Tyr-tub). TTL, in contrast with 
TTCP, prefers tubulin dimers as substrate so occurs exclusively 





Fig. 9. The tyrosination cycle of α-tubulin. The carboxy-terminal tyrosine of α-
tubulin can be removed by the tubulin tyrosine carboxypeptidase (TTCP) to 
generate Glu-tubulin (Glu-tub). In an ATP dependent reaction, the carboxy-
terminal tyrosine (Tyr-tub) can be restored through the enzymatic activity of 
tubulin tyrosine ligase (TTL). Glu-tubulin can lose the penultimate glutamate 
residue through the activity of an unknown peptidase to generate ∆2 tubulin, 
which cannot function as substrate for TTL and is therefore removed from the 
cycle (From Westermann and Weber, 2003). 
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Although detyrosination itself does not stabilize microtubules, it is 
considered marker of dynamic microtubule. Moreover, 
detyrosination is thought to be crucial for the cross-talk of 
microtubule and intermediate filaments as well (Gurland et al., 
1995) (Table 2). It has been shown that α-tubulin can incorporate 3-
nitrotyrosine, a modified amino acid generated by the reaction of 
nitric oxide species with tyrosine. Interestingly, nitrotyrosination is 
catalyzed both in vivo and in vitro by the same enzyme, TTL, 
involved in tyrosination. It has been proposed that this incorporation 
is irreversible and that the accumulation of 3-nitrotyrosine leads to 
microtubule dysfunction and cellular injury (Zedda et al., 2004). 
 
Acetylation/deacetylation 
Acetylation is a well known post-translational modification that 
takes place at lysine-40 in the amino terminus of α-tubulin located in 
the lumen of microtubules (Nogales, 2001).  
Even if the tubulin acetylatransferase enzyme has not been 
identified, recently the two enzymes catalyzing the reaction of 
deacetylation has been found. The enzymes are two histones 
deacetylase: HDAC6 (Histone Deacetylase 6) and SIRT2 (Sirtuins 
2). HDAC6 belongs to the deacetylase family and it is mostly 
located in the cytoplasm in association with microtubules (Hubbert 
et al., 2002). SIRT2 is the namesake of a family of closely related 
enzymes, the sirtuins, that are hypothesized to play a key role in the 




Acetylation takes place after microtubule assembly. It is marker of 
stable microtubules being associated with stable microtubular 
structures such as axonemes (Sasse et al., 1988). Furthermore, has 
been proposed a role for tubulin acetylation in cell mobility on the 
basis of the fact that HADC6 over-expression increased the 
chemiotactic movements in cultured cell, whereas inhibition of the 
same enzyme blocks cell migration. 
 
Polyglutamylation  
Polyglutamilation is a not very usual form of reversible post-
translational modification of glutamate residues occurring in α-β 
dimers and in two nucleosome assembly proteins (NAP1 and 
NAP2). For this reason, it seems that chromatin structural proteins 
are regulated by this post-translational modification.  
In polyglutamylation, a polyglutamate side chain of variable length 
is attached, through an isopeptide bond, to the γ carboxy-group of a 
glutamate in the carboxy-terminal tail of tubulin (Boucher et al., 
1994). Polyglutamylase and polydeglutamylase are the enzymes 
involved in glutamylation/deglutamylation processes. 
Recent findings have revealed a prominent role of polyglutamylation 
in the interaction between microtubules and their associated proteins 
(i.e. MAPs 55) in centriole maturation/stability (Gagnon et al., 1996) 




It is the most important post-translational modification of axonemal 
microtubule. Polyglicylation is the covalent attachment of a 
polyglycine side chain through an isopeptide bond to the carboxyl 
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group of conserved glutamate residues at the carboxyl-terminus of α-
β tubulin. This modification was originally discovered in 
Paramecium (Redeker et al., 1994) and later shown in mammalian 
neurons as well (Banerjee et al., 2002). 
Presently, the enzymes catalyzing polyglycylation are not known. 
Genetic studies carried out on Tetrahymena thermophila have 
provided some information about the possible functions of 
polyglycylation. In Tetrahymena polyglycylation is essential for 
cellular activities related to axonemal organization, ciliary motility 
and cytokinesis (Xia et al., 2000) (Table 2). 
 
Palmitoylation 
Palmitoylation consists in the incorporation of the palmitic acid on 
the α-subunit at cysteine 376 (Caron et al., 1997). Studies carried out 
on the budding yeast Saccharomyces cerevisiae revealed that 
palmitoylation of α-tubulin is necessary for the correct positioning of 
astral microtubules and for the right microtubule interactions with 
the cell cortex (Caron et al., 2001) (Table 2). 
 
Phosphorylation 
Phosphorylation is not a common post-translational modification. It 
consists in the phosphorylation of a serine residue within the 
carboxy-terminal tail of β-tubulin. Phosphorylation plays a crucial 
role in the regulation of some MAPs and may be involved in  
neuronal differentiation since it regulates the axon outgrowth of 











































Table 2. Overview of the various tubulins modifications and their proposed functions 
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Steroid hormones are mainly synthesized in the adrenal glands, the 
gonads and the feto-placental organ. They can easily cross the blood-
brain barrier because of their high lipid solubility. The central and 
peripheral nervous systems are crucial target organs of steroid 
hormones. Moreover, an extensive steroid metabolism occurs in the 
brain, several brain regions and peripheral nervous system. Indeed, 
each of these areas are equipped with the enzymes necessary for the 
synthesis of steroid as well. The synthesis of steroids may take place 
particularly, but not exclusively, in myelinating glial cells, from 
cholesterol or steroidal precursors deriving from peripheral sources. 
Steroids have been found to play a pivotal role in the development, 
growth, maturation and differentiation of human brain. Indeed, the 
activity of steroidogenic enzymes have been identified in specific 
areas of human fetal brain.  
 
Neurosteroids 
The term neurosteroids was firstly defined by Baulieu and co-
workers (Baulieu et al., 1990). They discovered that a number of 
steroid hormones existed in higher concentrations in the nervous 
system than in the plasma and that these steroids were synthesized in 
the brain. Nowadays it is known that neurosteroids can be 
metabolized in the brain from precursor compounds originating from 






Neuroactive steroids are steroids that produce a rapid, non-genomic 
action in the brain, generally through the action on ligand - or 
voltage-gated channels (Stoffel-Wagner, 2001). For this reason 
neuroactive steroids differ significantly from classic steroid 
hormones since they mainly act upon intracellular receptors resulting 
in a long lasting, genomic effect (Truss et al., 1988). Neuroactive 
steroids can either positively or negatively modulate the activity of 
several ligand-gated ion channel-associated receptors including γ-
aminobutyric acid type A (GABAA), serotonin type 3 (5-HT3), 
glycine and glutamate N-methyl-D-aspartate (NMDAA), α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainite 
receptors.  
Examples of neuroactive steroids are: a) the pregnane steroids 4-
pregnene-3,20-dione (progesterone, P), 3β-OH-5-pregnen-20-one 
(pregnenolone, Preg), pregnenolone sulphate (PregS), 3α-OH-5β-
pregnan-20-one (pregnanolone), 3α-hydroxy-5α-pregnan-20-one 
(allopregnanolone, ALLO), 3α,21-dihydroxy-5α-pregnan-20-one 
(allotetrahydrodeoxycorticosterone, THDOC), 
dihydrodeoxycorticosterone (DHDOC) b)androstane steroids OH-
androst-5-en-20-one (dehydroepiandrosterone, DHEA) and DHEA-
sulphate (DHEAS).  
As mentioned above, neuroactive steroids can exert a bimodal 
activity since some are agonist, they are known as GABA-agonist 
(i.e. THDOC), and other neurosteroids are antagonists, the so called 
GABA antagonists (i.e. P, DHEA, DHEAS). Moreover, the binding 
of specific neuroactive steroids (i.e. 3α-reduced neurosteroids) to 
GABAA receptors can lead to either inhibition or enhancement of 
GABA inhibitory effects (Majewska, 1992). For this reason it is 
clear that neuroactive steroids play a crucial role in mediating many 
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brain functions and activities. For instance, pregenenolone sulfate 
and DHEAS-induced (GABA-antagonist) inhibition of GABAA 
receptors may determine effects ranging from anxiety and 
excitability to seizure susceptibility. Moreover, DHEA and DHEAS, 
the most abundant circulating neuroactive steroids hormones in 
humans, can exert a neuroprotective action (Baulieu et al., 1998). 
Interestingly, a correlation between the decrease in DHEA and 
DHEAS concentrations, that are strictly related to age and stress 
conditions, and neuronal vulnerability to degeneration has been 
established. For instance, marked decrease of DHEA and DHEAS 
concentrations have been reported in patients affected by 
neurodegenerative diseases such as Alzheimer's disease and multi-
infarct dementia (Näsman et al., 1991; Magri et al., 2000). 
Neuroprotection by DHEA and DHEAS was also observed in vivo, 
whereas the mechanisms by they act are still unknown (Baulieu et 
al., 1998).  
In addition, great deal of investigations have ascertained a 
correlation between effects of sex hormones and human cognitive 
functions. The most prominent examples are the effects of 
oestrogens and androgens on verbal fluency, the performance of 
spatial tasks, verbal memory tests and fine-motor skills (Hampson et 
al., 1990; Phillips and Sherwin, 1992a; Phillips and Sherwin, 
1992b). 
There is a considerable documentation about oestrogenic influences 
on brain morphology and neurochemistry including the enhancement 
of the cholinergic system that is involved in learning and memory 
(McEwen et al., 1995; McEwen and Alves, 1999). All brain 
activities induced by neuroactive steroids are subjected to sex-
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specific differences. Thus, oestrogen effects differ quantitatively or 
qualitatively between sexes.  
Finally, oestrogens may exert neurotrophic and neuroprotective 
effects such as induction of neuritis outgrowth, dendritic spines, and 
synaptogenesis. They also influence the neuronal excitability, 
improve gene expression and exhibit intrinsic antioxidant activity 
(McEwen and Alves, 1999).  
 
Fig. 10. Steroids hormones pathways. 
 
Steroid synthesis in the brain: conversion of cholesterol to 
pregnenolone 
The first step in the synthesis of all steroid hormones is the 
conversion of cholesterol to pregnenolone, catalyzed by the enzyme 
cytochrome P450 cholesterol side-chain cleavage enzyme (PS450scc) 
(Fig. 10). In addition to adrenal glands and gonads that are the main 
sources of steroid production, P450scc is also present in the placenta, 
primitive gut and brain (Mellon et al., 1993). 
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Recently, it has been identified the localization of P450scc mRNA in 
specific areas of human brain. High amounts of P450scc mRNA were 
found in temporal and frontal neocortex, subcortical white matter 
from the temporal lobe and in the hippocampus of children and 
adults. Interestingly, concentrations in the temporal lobe increase 
markedly during childhood and reach adult levels at puberty. 
Moreover, P450scc mRNA levels were significantly higher in the 
temporal and frontal neocortex as well as in the hippocampus of 
women in comparison with men (Beyenburg et al., 1999). These 
data establish a crucial age- and sex-dependent expression of P450scc 
mRNA in the human brain and provide clear evidence that 
pregnenolone can be synthesized in the central nervous system.  
 
Steroid synthesis in the brain: conversion of androgens to 
estrogens 
Cytochrome P450 aromatase catalyzes the conversion of androgens 
to estrogens in specific temporal and frontal brain areas (Fig. 10). 
Androgens may be metabolized in the brain following two different 
pathways. The aromatase pathway consists in the transformation of 
testosterone into estradiol and androstenedione into estrone; this is 
similar to 5α-reductase pathway which converts testosterone into 
dihydrotestosterone and occurs in the majority of the peripheral 
androgen dependent structures (e.g. prostate).  
Aromatase activity has been found higher in the placenta than in the 
human brain. Moreover, aromatase activity both in temporal and in 
frontal brain areas has been demonstrated. Interestingly, frontal 
aromatase activity was always higher than temporal aromatase 
activity regardless of sex and/or disease state. By contrast, in 
temporal lobe and hippocampus, the brain areas in which 5α-
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reductase was ascertained, the expression levels of 5α-reductase are 
very similar (Wozniak et al., 1998).  
 
3β-hydroxysteroid dehydrogenase: inactivation of metabolite of  
steroid hormones 
In liver metabolism, 3β-hydroxysteroid dehydrogenase (3β-HSD) 
plays an essential role leading to physiologically inactive metabolites 
of steroid hormones (Fig. 10). However, three functional 3β-HSD 
isozymes (type 1, 2 and 3) have been characterized on the basis of 
their affinity for 5α-dihydrotestosterone. The isozyme 1 is expressed 
exclusively in the liver, whereas the isozyme 2 is present both in the 
human hippocampus and liver (Khanna et al., 1995). 
 
17β-hydroxysteroid dehydrogenase: regulation of the biological 
activity of steroid hormones  
There are seven human isozymes of 17β-hydroxysteroid 
dehydrogenase (17β-HSD) (Fig. 10). 17β-HSD plays a crucial role in 
the regulation of the biological activity of sex hormones. 17β-HSD is 
essential for the biosynthesis of the strong androgens and oestrogens, 
(testosterone and estradiol) from their weaker precursors 
androstenedione and estrone (Peltoketo et al., 1999). These 
conversions are reversible and thus can lead to a deactivation of the 
respective sex hormones. The different isozymes show an individual 
cell-specific expression as well as a typical substrate specificity. The 
importance of the 17β-HSD activity in the maintenance of 
physiological levels of estradiol and testosterone is reflected by its 
ubiquitous distribution in peripheral tissues. As it regards the central 
nervous system, 17β-HSD expression has been ascertained not only 
in specific areas of the adult brain such as human temporal lobe and 
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hippocampus but also in human fetal brain. The expression levels of 
17β-HSD are significantly higher in the subcortical white matter 
than in the cerebral neocortex. The main expression of 17β-HSD in 
the subcortical white matter suggests that glial cells could play a role 
in the biosynthesis and deactivation of sex steroids in the brain. 
Finally, there is no sexual dimorphism in the expression or activity 
























2-METHOXYESTRADIOL: BIOCHEMICAL FEATURES AND 
ITS ACTIVITY IN VITRO AND IN VIVO 
 
General features 
2-Methoxyestradiol (2ME) (Fig. 11) is an endogenous steroid 
metabolite of 17β–estradiol. It has been developed as a novel 
antitumor agent for its extreme effectiveness in several cancer lines 
in vitro and in vivo. 2ME may also be active in cells of central and 
peripheral nervous system. Peculiar mechanisms of 2ME action 
make this molecule extremely attractive for the study of the 
pathogenesis and the treatment of several diseases occurring in the 
nervous system.  
 
Biochemical and physiological properties 
2ME is one of the most biologically active endogenous metabolite 
of 17β-estradiol (E2). E2 is metabolized to 2-hydroxyestradiol 
(2OH) through cytochrome P450scc by a 
NADPH-dependent cytochrome P450-
linked monooxygenase system. Then, 
2OH is rapidly O-methylated at the 2-
position by ubiquitously present catecol-
O-methyltransferase to 2ME 
(Brueggemeier et al., 1989). 2ME binds the sex hormone-binding 
globulin (SHBG) in the blood and represents a fundamental step in 
the elimination of the potentially toxic cathecol oestrogens 
produced by proliferating cells (Gelbke et al., 1976; Dawling et al., 
2001). 2ME plasma levels of women are higher than those found in 
men and they can be even more elevated during pregnancy (Berg et 
al., 1992).  
Fig. 11. 2-Methoxyestradiol. 
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2-Methoxyestradiol affinity for oestrogen receptors 
In spite of the fact that 2ME has a biochemical similarity with 17β-
estradiol, other oestrogens and several their metabolites, 2ME 
estrogenic activity and its affinity for oestrogen receptors (ERs: 
ERα, ERβ, ERαβ subtypes) are still matter of debate.  
Firstly, Martucci and Fishman have showed that 2ME has a low 
binding affinity for uterine cytosolic ERs and a very low biological 
activity as a conventional oestrogen. Indeed, these Authors have 
seen that continuous administrations of 2ME in ovariectomized rats 
did not exert any uterotrophic activity and did not modify LH 
plasma level (Martucci and Fishman, 1979). By contrast, in 
HUVEC (Umbilical Vein Endothelial Cells), MDA-MB-435 and 
MDA-MB-231 (Human Breast Carcinomas Cells) cell lines, 2ME 
has been probed exerting a significant binding affinity for ERα 
even if its biological activity was independent from ERs activation 
(LaVallee et al., 2002).  
The above mentioned results disagree with findings provided by 
Banerjee and co-workers. Exposing GH3 (Rat Pituitary Tumor 
Cells), MCF-7 (Epithelial Tumour Cells) and MIA-Pa-Ca-2 
(Pancreatic Adenocarcinoma Cells) cell lines to 2ME micromolar 
concentration, these Authors have demonstrated that, not only has 
2ME a high binding affinity for ERs-α but also it can modulate 
ERs-α activation. Interestingly, 2ME seemed to exert a biphasic 
effect in cellular function being a stimulus for cell growth at low 
doses and having a reversed action at higher concentrations 
(Banerjee et al., 2003). 
Finally, a study carried out on 2ME-exposed MCF-7 (Epithelial 
Tumoral Cells) cell line has supplied further data that make 
stronger Banerjee’s hypothesis. Indeed, a direct link between 2ME 
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effects and 2ME affinity for ERs has been clearly established. 
Taking into account Authors’ conclusions, the common notion 
about 2ME low affinity for ERs should has come from mere 
methodological misunderstandings. Indeed, a new methological 
approach has let them to find a direct link between 2ME high 
affinity to ERs as a real oestrogen agonist and 2ME biological 
activity even inducing, in this case, tumour growth (Sutherland et 
al., 2005). 
 
2-Methoxyestradiol has an antiangionetic activity: inhibition of 
HIF-1 alpha expression 
2ME was initially considered as a direct inhibitor of angiogenesis 
since it strongly inhibits endothelial cell proliferation and cell 
migration in vitro. Moreover, oral 2ME-administration in mice has 
been seen reducing the neovascularization and suppressing growth 
of solid tumours (Fotsis et al., 1994). The mechanisms involved in 
such a 2ME-antiangionetic activity have been partially clarified. 
Studies carried out on MDA-MB-231 (Human Breast Cancer 
Cells), PC-3 (Human Prostatic Cancer Cells) cell lines and 
endothelial cells have revealed that 2ME-antiangiogenic activity is 
mediated through inhibition of HIF-1α expression. HIF-1α, a 
heterodimer of α and β subunits, is a proangiogenic transcription 
factor that interacts with some hypoxia response elements (HREs) 
and enhances the transcription of multiple proangiogenic proteins 
including VEGF-A (Vascular Endothelial Growth Factor). In 
normotoxic conditions, HIF-1α is degraded by the proteasome 
system, whereas it can be stabilized by hypoxia conditions 
(Mabjeesh et al., 2003). A recent study has presented new 
evidences on the role of 2ME as inhibitor of angiogenesis. It has 
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been highlighted that 2ME can determine a marked 
depolymerization of the microtubules in EC (Endothelial Human 
Pulmonary Cells) cell line inducing evident lung vascular barrier 
dysfunctions (Bogatcheva et al., 2007). 
 
2-Methoxyestradiol exerts an antimitotic activity: abnormal 
spindle, tubulin depolymerization & alteration of tubulin 
dynamics 
Antimitotic activity was the first mechanism that has been 
discovered being cause of 2ME cytotoxic effect in vitro. Since 
almost 20 years ago, Seegers and co-workers have probed that 2ME 
determined anomalies during cellular mitosis at high concentrations 
(between 10 and 25µM). In MCF-7 (Human Breast 
Adenocarcinoma Cells) and HeLa (Human Cervical 
Adenocarcinoma Cells) 2ME exposed-cell lines, 2ME was 
discovered to determine an abnormal and fragmented spindle 
formation (also known as bipolar) with disoriented microtubular 
arrangement in the metaphase of dividing cells (Seegers et al., 
1989).  
 Abnormal polymerization of mitotic spindle was observed in SK-
OV-3 (Human Ovarian Carcinoma Cells), HeLa (Human Cervical 
Carcinoma Cells), PC3 and DU 145 (Human Prostate Carcinomas 
Cells) cell lines as well. Low 2ME micromolar concentrations have 
been seen interfering with the normal polymerization of the mitotic 
spindle microtubules. Indeed, anomalous spindles appeared to be 
short and not properly organized so that the consequent 
dysfunctional alignment of DNA determined the mitotic arrest. 
Moreover, high 2ME micromolar concentrations exposure could 
trigger a marked tubulin depolymerization. In details, from 5 to 
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10µM 2ME micromolar exposure, 50% of microtubules were lost, 
whereas a complete inhibition of tubulin polymerization was 
observed between 16.6 and 19.9µM 2ME exposure (Tinley et al., 
2003). 
By contrast, some studies have hypothesized that 2ME exerts its 
antimitotic activity more intensively altering tubulin dynamics 
rather than determining microtubular depolymerization. In a study 
carried out on MCF-7 (Human Mammary Carcinoma Cells) cell 
line, Attalla and co-workers have reported that, the mitosis block 
following 2ME micromolar concentration (between 5 and 20 µM) 
exposure was not exclusively accompanied by depolymerization of 
tubulin and resultant inhibition of mitotic spindle assembly. The 
mere defect in mitosis was confirmed by the arrest of chromosomes 
in the metaphasal plate since cells whose mitosis was blocked by a 
tubulin depolymerizing drug (i.e. colcemide) showed their 
chromosomes dispersed in the cytoplasm. According to this study, 
2ME mitosis-block is similarly induced by several anti-calmodulin 
agents or some compounds that affect  microtubules dynamics (i.e. 
taxol and vinblastine). Thus, given the fact that metaphase to 
anaphase transition is a calmodulin-dependent step and 2ME 
inhibits calmodulin activity in vitro, 2ME metaphasal arrest has 
been proposed to occur via inhibition of calmodulin (Attalla et al., 
1996).  
Brueggemeier and co-workers., agree with the hypothesis that 2ME 
antimitotic effect is due to 2ME-induced alteration of microtubular 
dynamics rather than the solely microtubule depolymerization. 
These Authors have ascertained that bipolar spindle formation, 
block of mitosis and disruption of microtubules in MCF-7/ER+, 
MDA-MBA-231/ER (Breast Cancer Cells) cell lines were induced 
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starting from 8.7µM exposure (Brueggemeier et al., 2001). 
Recently, Kamath and co-workers have provided new evidences 
about such 2ME property. In details, they ascertained that in MCF7 
(Human Mammary Carcinoma Cell) cell line  2ME-induced mitotic 
arrest was not accompanied by detectable microtubular 
depolymerization. The Authors found that tubulin depolymerisation 
2ME-induced needed 2ME concentrations higher than those 
necessary to affect microtubular dynamics. These findings support 
the assumption that, at its lowest effective concentrations, 2ME 
may cause mitotic arrest and suppress microtubular dynamics by 
stopping microtubule growth parameters, increasing the time of 
steady-state and interfering with chromosome progression or cell 
division. This hypothesis could be also reinforced by the fact that 
the mitosis block 2ME-induced on actively dividing cells is more 
effective if they have a high proliferation rate (Kamath et al., 
2006). 
 
2-Methoxyestradiol alters cell mobility, cell adhesion and trans-
well migration 
2ME cytotoxic activity could be related to the alteration of other 
cytoskeletal functions such as cell motility, cell adhesion and trans-
well migration. 2ME was established to  arrest spontaneous  BCR-
ABL transformed Ba/F3 cells (Mouse Peripheral Blood, pro B) 
mobility by changing their morphology and volume. Cells exposed 
to micromolar 2ME concentrations (from 1 to 5µM) showed a 
reduction in number of pseudopodia and were detached from 
fibronectin-coated surfaces in which they have grown. In addition, 
2ME markedly inhibited the spontaneous cell migration trough a 
trans-well membrane. Functional modifications were  accompanied 
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by depolymerization of tubulin, appearance of disorganized 
microtubules and nuclear morphological features typical of 
defective mitosis. Taken together, these data suggest that 2ME 
regulates multiple cellular functions related to the main 
physiological cytoskeletal activities (Sattler et al., 2003). 
 
2-Methoxyestradiol interacts with tubulin and inhibits 
colchicine–binding site in vitro and in vivo 
Depending on the in vitro reaction conditions, 2ME can bind to the 
colchicine site of tubulin, be incorporated in a polymer resulting in 
altered stability properties or block tubulin polymerization. In 
presence of 1.0M glutamate/1.0mµ and MgCl2 at 37°C, 2ME 
arrests the nucleation and propagation phase of tubulin assembly, 
whereas do not interfere with the reaction extent. Interestingly, the 
polymer formed in presence of 2ME is cold-stable and has little 
morphological abnormalities. Under sub-optimal conditions (0.8M 
glutamate/absence of MgCl2 at 25-30°C) 2ME could totally inhibit 
tubulin polymerization (D'Amato et al., 1994). 
2ME can bind to the colchicine binding-site of tubulin in 
unpolymerizated α-β tubulin dimers as well. In glutamate-induced 
tubulin assembly and in preformed tubulin, significant amounts of 
2ME interact with tubulin forming abnormal polymers with altered 
properties (Hamel et al., 1996). The complete block of tubulin 
polymerization in MDA-MB-435 cells (Human Breast Cancer 
Cells) has confirmed the 2ME capability to bind the colchicine 
binding-site (Cushman et al., 1995).  
 
2-Methoxyestradiol induces apoptosis 
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2ME can induce apoptosis in cancer cell lines through several 
pathways. 2ME may determine inhibition of the transcription of 
superoxide dismutase (SOD) which protects cellular from damage 
and cell death determined by superoxide radicals. Tumour cells are 
more dependent on SOD than normal cells, since they have a 
higher superoxide production but a lower level of SOD than normal 
cells (Huang et al., 2003). This is one of the mechanisms by which 
2ME is extremely effective in fast-growing cells (i.e. cancer cells), 
whereas it does not affect slow-growing cells (i.e. normal cells). 
When exposed to 2ME micromolar concentrations (from 1 to 
2µM), normal skin fibroblast strain HSF43 (Human Fibroblast 
Cells) is not susceptible to 2ME.  
In SV40 (Simian Vacuolating Virus 40) T antigen-transformed, 
HSF43 cell line, 2ME determines G2/M block, nuclear 
fragmentation, micronucleation and increase in p53 peculiar of 
apoptosis. The Authors argued that 2ME, being a microtubule 
poison, it may act as enhancer of 2ME apoptotic effect. Similar 
results were obtained from TK6 and WTK (Lymphoblast Cells) cell 
lines (Seegers et al., 1997).  
In addition, it has been ascertained that 2ME can start various 
mitogen-activated protein (MAP) kinases such as MAPKs/ERK, 
JNK or p38 MAPKs involved in the regulation of some cellular 
activities. MAPKs/ERK is a signal pathway coupling growth 
factors of intracellular responses to cell receptors. MAPKs/ERK is 
activated by mitogenic stimuli and plays a crucial role in regulation 
of cell proliferation and differentiation. Moreover, JNK and p38 
MAPK control gene expression, mitosis and cell differentiation or 
survival. JNK/p38 MAPK are triggered by pro-inflammatory 
cytokines and environmental stresses such as osmotic shock, UV 
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light, heat shock or growth factor withdrawal. Finally, Bcl-2, a 
family of genes and proteins that govern mitochondrial outer 
membrane permeabilisation (MOMP) and may be either pro-
apoptotic or anti-apoptotic factors, can be phosphorylated by 
MAPK kinases activation. Bcl-2 phosphorylation is a crucial 
biochemical event related to the triggering of cellular apoptosis. 
2ME through MAPK indirect or direct activation may induce Bcl-2 
phosphorylation and consequent cellular apoptosis. Several studies 
have highlighted this assumption. In K5628 (Human Erytromyeloid 
Leukemia) cell line, 2ME-induced microtubular damages may 
determine phoshorylation of Bcl-2 uncoupling from JNK/SAPK 
activation. However, the Authors hypothesized that JNK/SAPK is 
indirectly involved in the pathway that leads to Bcl-2 activation 
(Attalla et al., 1998). By contrast, in OVCAR-3 (Human Ovarian 
Carcinoma Cell) cell lines it was found that Bcl-2 phosphorylation 
is solely related to p38 MAPK activation, whereas JNK or ERK are 
not necessary to Bcl-2 phosphorylation (Bu et al., 2006). These 
findings disagree with a study carried out on LNCaP (Human 
Prostate Cancer Cells) cell line where JNK activation was 
discovered to be the crucial pathway implicating in Bcl-2 
phosphorylation. The data obtained let the Authors to form the 
hypothesis that, different mechanisms leading to Bcl-2 
phosphorylation may be due to MAPKs exhibition of cell-type 
specific responses (Shimada et al., 2003). 
 
2-Methoxyestradiol modifies tubulin expression 
Gokmen-Polar and co-workers has compared the effects of 2ME on 
stable 2ME-resistant cells with a β-tubulin mutation in MDA-MB-
435 (Human Breast Cancer Cells), W435 (Human Carcinoma 
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Cells) and P435 (Parental Cells) cell lines. A dose-dependent 
depolymerization of microtubules was observed when P435 cells 
were exposed to 2ME micromolar concentrations, whereas 2ME-
resistant cells remained unaffected. Indeed, IC50 were 0.38µM for 
P435, 12.29µM for W435 and 15.23µM for 2ME-resistant cells. 
Interestingly, levels of acetylated and detyrosinated α-tubulin 
decreased in P435 cells in a clear dose-dependent manner, while 
they were unchanged in 2ME-resistant cells. Taken together this 
data suggest that 2ME induces microtubules alteration only in cells 




















2-METHOXYESTRADIOL-EXPOSED GLIAL AND 
NEURONAL CELL LINES: LITERATURE REPORTS 
 
2-Methoxyestradiol-exposed cells of glial origin 
In a study carried out on DAOY, D341, D283 (Human 
Medulloblastoma Cells) cell lines and U87 and T98 (Human 
Astrocytoma/glioblastoma Cells) high-grade anaplastic cell lines, it 
has been shown that 2ME acts as inhibitor of cell growth more 
efficiently in tumour than in non-tumour cells. At 0.5, 1, 2 and 
3µM concentrations, 2ME causes 38%, 80% decrease in growth of 
astrocytoma/glioblastoma and medulloblastoma cells respectively, 
by blocking cycle progression mainly in G2/M phase. This study 
also proved that 2ME-mediated growth inhibition occurs with 
induction of apoptosis. Interestingly, 2ME-induced apoptosis was 
not accompanied by modification of the expression of p53 and Bax 
(Kumar et al., 2003).  
Moreover, another work carried out on U87, T98, U138 (Human 
Astrocytoma/glioblastoma Cells) cell lines and cultured rat 
astrocytes 2ME-exposed (from 0.001  to 10µM for 2 days) 
determined a marked growth inhibition (between 60% and 90%) 
only in glioblastoma cells. 2ME antiproliferative effect was 
accompanied by an increase in apoptotic cells with abnormal 
nuclear morphology. Treatment of U87, T98 and U138 cells with 
3.3µM 2ME resulted in 39%, 20% and 82% growth inhibition in 
comparison with control and cells were blocked at G2/M phase. In 
addition, elevated levels of the tumour suppressor protein p53 were 
only detectable in U87 and in rat astrocytes. According to the 
Authors’ conclusions, given the fact that rat astrocytes have a much 
slower proliferation rate than glioblastoma cells and that 2ME did 
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not induce nuclear alterations in astrocytes, 2ME appears to be less 
effective in astrocytes than in glioblastoma cells (Lis et al., 2004). 
Chamaon and co-workers observed that 2ME-exposure (0.2, 2 and 
20µM for 6 days) of U87, U138, LN405 (Human Glioblastoma 
Cells) cell lines and RG2 (Rat glioma Cell) cell line caused a 
significant reduction of the viable cell number. When compared 
with control, the drug-specific cell reduction was in the range 
between 10% and 40% for lower 2ME concentrations and between 
75% and 100% for higher 2ME concentrations. Caspase-3 activity 
increase, nuclear fragmentation and micronucleation in all 2ME-
treated cells, revealed the apoptotic nature of cell death. 
Interestingly, the Authors observed that during interphase, 2ME-
induced morphological alterations were not accompanied by 
complete distraction of microtubular network. These findings were 
suggestive that 2ME had no effect on interphase microtubules since 
it needed a much higher concentration to generate aberrant mitotic 
spindles resulting in mitotic block an induction of apoptosis 
(Chamaon et al., 2005).  
A recent study carried out on the cell lines above mentioned (U87, 
U138, LN405 and RG-2) confirmed that 2ME-exposure (2 and 
20µM for 24 and 78 h) determined a significant reduction of the 
viable cells number. Moreover, the death-inducing apoptotic 
mechanism was further probed by micronucleation and nuclear 
fragmentation, whereas the role of the death receptor 5 remained 
controversial. Indeed, short incubation with 2ME (20µM for 24 h) 
determined death-cell independently of death receptor 5 up-





2-Methoxyestradiol-exposed cells of neuronal origin 
Retinoic acid (RA)-differentiated human neuroblastoma (SH-
SY5Y) cell line was sensitive to 2ME in a concentration-dependent 
manner from 0.3 to 10µM 2ME micromolar exposure induced cell 
death and internucleosomal DNA fragmentation peculiar of 
defective mitosis. Interestingly, it has been found that 2ME may 
induce the protein synthesis inhibitors cycloheximide and apopain 
(Asp-Glu-Val-Asp-H, aldehyde) in inhibitor-sensitive neuronal cell 

























Previously published works have ascertained that neuronal 
differentiation occurs when neuronal cells show at least one 
cytoplasmic process longer than the main diameter of the cell body 
(Chang et al., 2006). Moreover, inhibition of cell proliferation, 
hypertrophy of cell bodies and nuclei, elongation of cytoplasmic 
processes, as well as the tendency to flatness and multipolarity of 
cells, are typical of differentiated neurons (Miyake et al., 1975). 
Axonal extension is accompanied by an increase in the number and 
length of microtubules, which in the axon are typically arranged 
parallel to the axis. Both intrinsic capability to elongate axons, and 
extrinsic signals, such as serum deprivation, dimethyl sulfoxide, 
retinoic acid, N6,2'-O-dibutyryl-adenosine-3',5'-cyclic-mono-
phosphate (db-cAMP) regulating the outgrowth at the axonal tip, 
play a role in cellular differentiation (Seyedin et al., 1981). 
Exposure to tapsigargin (TG) micromolar concentrations may also 
induce differentiation in rat glioma cells (C6). C6 cell 
differentiation results in a marked cell proliferation decrease and 
modification of cell morphology since cells from a round, flat 
shape acquire a typical spindle shape extending long cytoplasmic 










AIMS OF THE STUDY 
 
2ME is a novel antiangiogenic, cytotoxic and antimitotic drug 
candidate in phase I and II clinical trials for the treatment of a 
broad range of tumour types. 
As we reported, 2ME mainly acts inducing defective mitotis and 
alteration of tubulin dynamics. Indeed, 2ME directly interacts with 
tubulin, inhibits tubulin colchicine binding-site and induces 
abnormalities in polymerization of mitotic spindle resulting in a 
perturbation of tubulin expression. Interestingly, 2ME seems to be 
more effective in fast-growing cells (i.e. tumour cells) than in slow-
growing cells (i.e. normal cells). Cell line sensitivity may due to 
not only to the specific sensitiveness of cell phenotypes but also to 
the 2ME capability to interact more efficiently with cells having a 
high microtubular dynamic. 
Taking into account these assumptions, we provided an in vitro 
model of study in order to find new evidences about some 2ME 
mechanisms of action in the central nervous system (SNC). For this 
reason we chose two continuous cell line of glial (rat glioma, clone 
C6) and neuronal origin (mouse neuroblastoma, clone C1300) 
representative of the main SNC cellular phenotypes. Moreover, 
since C6 and C1300 are fast-growing and highly proliferating cell 
lines, they may represent an useful model for the comprehension of 
mechanisms by which 2ME exerts its antimitotic and cytotoxic 
action. In addition, we studied 2ME action on differentiated C6, 
C1300 cell lines with the aim to systematically compare the relative 
effectiveness of 2ME toxicity on undifferentiated fast-growing cell 




To summarize, purposes of this work are: 
 
- find possible differences in the relative effectiveness of 2ME 
toxicity on cells of glial and neuronal origin; 
- systematically compare possible differences in the relative 
effectiveness of 2ME toxicity on undifferentiated fast-growing cell 
lines and differentiated slow-growing cell lines of glial and 
neuronal origin. 
 
In order to evaluate the relative effectiveness of 2ME we provided 
a study on morphological features, cell vitality, cell proliferation 
and tubulin dynamics in C6/C1300 undifferentiated/differentiated 
cells undergone experimental protocols. 
In conclusion, this study would like to contribute to 2ME activities 
knowledge on cells of glial and neuronal origin in vitro and it is 














































Cell culture and treatments 
In the present work were used two continuous cell lines: rat glioma 
(C6) and murine nuroblastoma (C1300) cells. Indirect 
immunofluorescence assessed the specific cellular phenotype: 
antibodies to glial fibrillary acidic protein (GFAP), an intermediate-
filament (IF) protein that is highly specific for astroglial lineage 
cells, and anti-β-tubulin class III, marker of neuronal cells, were 
applied for C6 and C1300 cell lines respectively (Fig. 12).  
Cells came from the Istituto Zooprofilattico Sperimentale della 
Lombardia e dell’Emilia (American Type Culture Collection, 
Rockville, MD, USA). 
C6 and C1300 cell lines at passage 60 were cultured in basal 
phenol-red-free RPMI-1640 medium supplemented with 10% heat 
inactivated dextran-coated charcoal-stripped newborn calf serum, 
2µM L-glutamine, 100 units/ml penicillin G and 100 µg/ml 
streptomycin sulphate. Cells were seeded in 75 cm2 flasks with 
basal medium at the concentration of 5.6X105 per ml and they 
grown at 37°C in a 5% CO2 humidified atmosphere. Only basal 
medium was used for control cells; the amounts of 2ME (Sigma) 
were added to the basal medium. Final 2ME micromolar 
concentrations (0.01, 0.1, 1, 5, 10µM) were chosen taking into 
account data from literature (Lis et al., 2003, Chamaon et al., 
2005). Moreover, 2ME micromolar concentrations were serially 
diluted from a stock solution containing 20 mg of 2ME dissolved in 
1 ml DMSO (0.00001% v/v). Since DMSO could have a toxic 
effect on cells, a further control was set by incubating cells in basal 
medium containing DMSO at the same concentration applied to 
dissolve 2ME (DMSO control cells). Cells were treated with the 
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toxic for 5 days, after 3 days the culture medium was replaced by 
fresh medium.  
C6 and C1300 cells were differentiated adding 4µM of tapsigargin 
and 10µM of db-cAMP respectively to the basal medium. Cells 
were treated for 5 days, after 3 days the medium was replaced by 
fresh medium.  
Finally, differentiated monolayers were exposed to 2ME 
micromolar concentrations (0.1, 1 and 5µM) and cultured following 
the above mentioned experimental conditions.  
 
Microscopic examination and cell proliferation assay (MTT 
test) 
In order to estimate morphological features, undifferentiated and 
differentiated C6, C1300 monolayers were daily observed in the 
living state under phase-contrast optics (PHACO) at 20X 
magnification with an inverted microscope (Leitz, DMIL) and 
photographed by a digital camera. Pictures were captured in bitmap 
format.  
Evaluation of cell growth rate on undifferentiated C6 and C1300 
cells (MTT test) was performed. Cells were plated in 96-well plates 
containing  50x103 cells in 200µl of basal medium and then 
exposed to the different 2ME micromolar concentration (0.01, 0.1, 
1, 5, 10µM) following the above indicated experimental protocols. 
After 5 days of treatment, cells were incubated in 3-(4,5-
dimethilthiazolyl-2)-2,5-diphenyltetrazolium bromide assay (MTT 
Cell Titer96®, Promega, Madison, WI, USA) for 1h. MTT was 
bioreduced by living cells into a colored formazan product that is 
soluble in culture medium. Absorption values were read setting the 
automatic microtiter reader at 492nm (Uniskan II, Labsystem, 
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Helsinki, Finland). This method correlates absorbance reading to 
the number of living cells. 
MTT test was also carried out on differentiated cells. 
Undifferentiated C6 and C1300 cells were seeded in 96-well plates 
containing 50x103 cells in 200µl and treated with 4µM of 
tapsigargin and 10µM of db-cAMP for 5 days. After differentiation 
cells were exposed to 2ME micromolar concentrations (0.1, 1, 
5µM) taking into account the above-mentioned protocols. 
  
Indirect immunofluorescence 
In order to determine markers of specific cellular phenotype, 
indirect immunofluorescence was performed.  
Cells were seeded and cultured for 48 h on chamber slides, then 
fixed in methanol at –20°C for 10 minutes, rinsed 3 x 10 min in 
PBS and finally blocked in 10% normal goat serum (NGS). 
With the aim at identifying  the astroglial lineage, monoclonal 
antibody against glial fibrillary acidic protein (GFAP) (clone G-A-
5; Sigma, St. Louis, MO, USA) at dilution of 1:400 for 1 hour at 
37°C was used. GFAP was detected by fluorescin isotiocyanate 
(FITC) conjugated anti-mouse (Sigma) secondary antibody (1:128 
dilution). 
To label neuronal phenotypes, monoclonal antibody against β-
tubulin class III (clone SDL-3D10, Sigma) was applied at the 
dilution of 1:800 for 1 h followed by fluorescin isotiocyanate 
(FITC) conjugated anti-mouse (Sigma) secondary antibody (1:128 
dilution). 
After the immunochemistry the slides were mounted, observed at 
20X magnification with UV fluorescent inverted microscope (Leitz
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DMIL) and photographed by a digital camera. Pictures were 
captured in a bitmap format. 
 
Staining with Hoechst H33342/propidium iodide (PI): viability 
assay  
Hoechst H33342/propidium iodide (PI) staining was performed to 
get cell viability estimation. Differentiated and undifferentiated C6, 
C1300 cells were cultured on chambers slides and underwent all 
protocols above indicating. The vital cells were stained with 
Hoechst 33342 (Sigma), while death cells were stained with 
propidium iodide (Sigma). 
After 5 min the cells were observed using a UV fluorescent 
inverted microscope (Leitz, DMIL) using the UV filter to visualize 
both dyes simultaneously. The nuclei of the viable cells were blue 
(Hoechst +ve) and morphologically normal. Death cells were bright 
orange/red stained. This direct staining method allowed all dead 
cells to be counted. The cell death rate was estimated as dead cell 
vs total cell number x 100 and intra-observer and inter-observer 
variability were each <2%. 
 
Western blot 
Cells were suspended in microtubule-stabilizing solution (5µM 
TRIS HCl pH 8.0, 2µM EGTA, 0.1µM phenylmethylsulfonyl 
fluoride), supplemented with protease inhibitors (Complete-mini, 
Roche, Basel, Switzerland). Cells were homogenized mechanically 
and then sonicated. Protein content was determined (DC Protein 
Assay, BioRad, Hercules, CA, USA) and aliquots of 15µg proteins 
each were fractionated in SDS-PAGE 12% gel and after that 
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transferred onto nitrocellulose membranes. Non-specific protein 
binding was blocked incubating membranes with 0.1% Tween 20 
and 5% skim milk in PBS. Nitrocellulose membranes were 
incubated with primary monoclonal antibodies against total α-
tubulin (clone DM1A, Sigma), acetylated-α-tubulin (clone 6-11B-1, 
Sigma), tyrosinated α-tubulin (clone TUB-1A2, Sigma), overnight 
at 4°C at 1:500, 1:500, 1:1.000 dilution respectively. An anti-mouse 
IgG-alkaline phosphatase-conjugated antibody (Anti-mouse Ig-AP, 
Fab fragment, Roche) was used at 1:1.000 dilution for 1h at room 
temperature. The immunoreactive bands were visualized by 
incubating the membrane with nitro blue tetrazolium/5-bromo-4-
chloro-3-indolyl phosphate (NBT/BCIP) (Roche) and heat fixed. 
Signals were quantified using Scion Image software. The anti α-
tubulin antibody visualized the α-tubulin subunits as a single band 
located approximately 55kDa. 
 
Statistical analysis 
All data were expressed as % of control (mean ±SEM) of 4-6 single 
experiments. Data were analyzed using Student’s t-test. Statistical 





              
 
 
                
 
 
Fig. 12. Indirect immunofluorescence assessed the specific cellular phenotype: 
glial fibrillary acidic protein (GFAP), an intermediate-filament (IF) protein that 
is highly specific for cells of astroglial  lineage and anti-β-tubulin class III as 
marker of neuronal cells were applied for undifferentiated C6 and C1300 cell 
lines respectively. Cells were viewed using a fluorescence microscope at 40X.     































UNDIFFERENTIATED C6 & C1300 CELLS 
 
In the initial experiments we found that both cell lines were 
sensitive to the toxic effects of 2ME at micromolar concentrations 
(0.01, 0.1, 1, 5 and 10µM for 5 days) but undifferentiated C1300 
cells were more sensitive than undifferentiated C6 cells.  
 
PHACO: microscopic examination 
Undifferentiated C6 control cells, 0.01 and 0.1µM 2ME-exposed 
cells were confluent and uniform in size. If compared with control 
cells, 1µM 2ME-treated cells were reduced in number (about 30%), 
whereas 5 and 10µM 2ME-exposed cells displayed morphological 
alterations, such as flatness, globular shape and presence of 
cytoplasmic vacuoles. In addition, most cells were detached from 
the dishes and retraction or absence of their cytoplasmic processes 
were observed (Fig. 13). 
Undifferentiated C1300 control cells were confluent at 90% and 
uniform in size; starting from 0.01µM cells were flat and shrunk 
and reduction in number (10% approximately) was ascertained. 
Reduction in number was more remarkable in 0.1µM (30% approx.) 
and mainly in 1µM (50% approx.) 2ME-treated-cells. At 5 and 
10µM a significant proportion of cells appeared detached from the 
dishes, exhibited numerous cytoplasmic vacuoles and lost their 
cytoplasmic processes (Fig. 15).  
 
Hoecst 33258/propidium iodide (PI) staining: viability test  
Hoechst 33258/propidium iodide (PI) staining revealed that 2ME-
induced nuclear damages and cell death were greater in 
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undifferentiated C1300 cells than in undifferentiated C6 cells at the 
same micromolar concentrations. 
Undifferentiated C6 control cells, 0.01 and 0.1µM 2ME-treated 
cells had single nuclei which were stained in blue by Hoechst dye, 
i.e. were viable. In 1, 5µM and mostly in 10µM 2ME-exposed 
monolayers, dead cells (about 30% at 1, 60% at 5 and 100% at 
10µM), nuclear fragmentation and micronucleation peculiar of 
defective mitosis were detectable (Fig. 14). 
Undifferentiated C1300 control cells had oval, homogeneous nuclei 
and did not display nuclear changes. About 20-40% of 0.01, 0.1 
and 1µM 2ME-exposed cells showed the PI red staining and 
morphological features characteristic of cell death. The percentage 
of dead cells was greater in 5 and 10µM exposed-cells where it was 
90-100% approximately (Fig. 16). 
 
MTT test: cell proliferation assay  
We examined the effect of 2ME on cell proliferation rate of 
undifferentiated C6 and C1300 cells using the MTT test 
(CellTiter96®). Cells underwent all protocols described in 
Materials & Methods and after 5 days of 2ME exposure cells 
proliferation rate was measured. Quantitative analysis of this 
phenomenon is shown in Fig. 17.  
Undifferentiated C6 cells showed from 1 µM concentration a 
gradual dose-dependent decrease (from -15 to -70%) in growth 
rate, when growth rate was fixed at 100% in control cells. 
Interestingly, 0.01 and 0.1µM exposure increased growth rate 
which was approximately +10, +5%. When compared to control 
cells, undifferentiated C1300 cells were sensitive to 2ME in a 
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marked dose-dependent manner: starting from 0.01µM a dramatic 
growth rate decline (from -30 to -90%) was ascertained. 
 
Western blot analysis  
2ME down-regulated the expression of tubulin both in 
undifferentiated C6 and C1300 cell lines in a dose-dependent 
manner. However, α-acetylated tubulin and mostly α-tyrosinated 
tubulin down-regulation is more intense in undifferentiated C1300 
than in undifferentiated C6 cells. 
 
Total α-tubulin 
Undifferentiated C6 cells: α–tubulin levels were %C= 78 ±2.5 in 
0.01µM 2ME-treated cells; protein expression similarly decreased 
in 0.1µM 2ME-exposed cells (%C= 62 ±1.3), 1µM-exposed (%C= 
55±3.6) and 5 µM (%C= 62 ±2.0) mono-layers and in 10µM-
treated cells (%C= 65 ±1.5) (Fig. 18).  
Undifferentiated C1300 cells: 2ME treatment slightly decreased α–
tubulin levels in 0.01µM and 0.1µM 2ME-treated cells (%C= 
91±2.1 and 81 ±1.8). Down-regulation was more marked in 1, 5 
and 10µM 2ME-exposed cells in which protein levels were %C= 
41 ±1.9, %C= 46 ±2.7, %C= 40 ±2.3 respectively (Fig. 19). 
 
Acetylated α-tubulin 
Undifferentiated C6 cells: levels of acetylated α-tubulin were %C= 
85 ±1.2 in 0.01µM 2ME-exposed cells decreasing in a dose 
dependent manner in 0.1µM (%C= 78 ±0.9), 1µM (%C = 68 ±1.7), 
5µM (%C= 68 ±1.5) and mostly in 10µM 2ME-treated cells (%C= 
55 ±0.4) (Fig. 20). 
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Undifferentiated C1300 cells: 2ME exposure did not modify the 
expression of acetylated α-tubulin at 0.01µM (%C= 100 ±2.2) and 
determined a slight down-regulation of its levels at 0.1µM (%C= 89 
±1.5) and 1µM (%C= 87 ±1.3). Levels of acetylated α-tubulin 
declined from %C= 51 ±0.5 to %C= 33 ±1.4 in 5 and 10µM 
respectively (Fig. 21). 
 
Tyrosinated α-tubulin 
Undifferentiated C6 cells: 2ME determined a slight down-
regulation of tyrosinated α-tubulin at 0.01µM (%C= 94 ±1.3). 
Protein levels dropped at 0.1µM (%C= 80 ±2.1), 1µM (%C = 76 
±2.4), 5µM (%C= 77 ±1.9) and mostly at 10µM (%C= 45 ±1.5) 
(Fig. 22). 
Undifferentiated C1300 cells: No significant modifications of 
tyrosinated α-tubulin expression were ascertained at 0.01 and 
0.1µM (%C= 95 ±2.5 and %C= 95 ±2.1 respectively). A constant 
dose-dependent decline was observed in 1 and 5µM (%C= 49 ±1.4 
and %C= 47 ±1.2),whereas in 10 µM 2ME-exposed cells levels of 












TAPSIGARGIN-DIFFERENTIATED C6 & db-cAMP-
DIFFERENTIATED C1300 CELLS 
In the last experiments we found that both tapsigargin-differentiated 
C6 and db-cAMP-differentiated C1300 cell lines were less sensitive 
than undifferentiated cells to the toxic effects of 2ME at 0.1, 1 and 
5µM for 5 days. Moreover, we ascertained that, between db-cAMP-
differentiated C1300 and tapsigargin-differentiated C6 cells, C1300 
cells were still more sensitive than C6 cells. 
 
PHACO: microscopic examination 
Tapsigargin-differentiated C6 and db-cAMP-differentiated C1300 
cells were confluent at 50% approximately. Cells were polygonal, 
uniform in size with hypertrophic cell body and displayed 
cytoplasmic processes up to ±70 µm long (Figg. 24, 26). 
After 2ME-treatment tapsigargin-differentiated C6 and db-cAMP-
differentiated C1300 cells kept a polygonal shape and long 
cytoplasmic processes but a reduction in number was evident in 1 
and 5µM 2ME-exposed monolayers. 5µM 2ME-exposed cells 
retracted most of their cytoplasmic processes and appeared shrunk 
with cytoplasmic vacuoles. Morphological alterations were more 
marked in db-cAMP-differentiated C1300 than in tapsigargin-
differentiated C6 cell lines (Figg. 24, 26). 
 
Hoecst 33258/propidium iodide (PI) staining: viability test  
Hoechst 33258/propidium iodide (PI) staining revealed that 2ME-
exposure determined nuclear damages and cell death in tapsigargin-
differentiated C6 and db-cAMP-differentiated C1300 cells. 
However, significant nuclear damages and cell death started to be 
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evident from 2ME micromolar concentrations which were higher 
than those detected in undifferentiated C6 and C1300 cells. 
Control cells and 0.1 µM 2ME-treated cells single nuclei which were 
stained in blue by Hoechst dye both in tapsigargin-differentiated C6 
and db-cAMP-differentiated C1300 cells. In 1 and 5µM exposed-
cells, nuclear fragmentation and micronucleation peculiar of 
defective mitosis were detected. The percentage in average of death 
cells was higher in db-cAMP C1300 differentiated cells (65% 
approximately) than  tapsigargin-differentiated C6 cells (about 40%) 
at the same concentrations (Figg. 25, 27).  
 
MTT test: cell proliferation assay 
We examined the effects of 2ME on cell viability of tapsigargin-
differentiated C6 and  db-cAMP-differentiated C1300 cell lines 
using the MTT test (CellTiter96®). Cells underwent all protocols 
described in Materials & Methods and after 5 days of 2ME exposure 
the cells proliferation rate was measured. Quantitative analysis of 
this phenomenon is shown in Fig. 28. 
Tapsigargin-differentiated C6 cells showed a decrease in the number 
of viable cells (-20%) in 0.1µM 2ME exposed cells, when growth 
rate was fixed at 100% in control cells. At 1 and 5µM the drop of the 
growth rate was more remarkable (-80%).  
db-cAMP-differentiated C1300 cells appeared to be more sensitive 
than tapsigargin-differentiated C6 cells since the growth rate at 
0.1µM was - 60% and at 1µM, at 5µM between -85, -90%. 
 
Western blot analysis  
2ME determines a slight down-regulation of total α-tubulin, 
tyrosinated α-tubulin and up-regulated acetylated α-tubulin 
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expression both in tapsigargin-differentiated C6 and db-cAMP-
differentiated C1300 cells. Down-regulation is higher in db-cAMP-
differentiated C1300 than tapsigargin-differentiated C6, whereas up-




Tapsigargin-differentiated C6 cells: 2ME determined a slight down-
regulation of total α–tubulin expression in 0.1µM (%C= 94±2.7). At 
1 and 5µM levels of protein were %C= 87±0.5 and %C= 80±3.1 % 
respectively (Fig. 29).  
db-cAMP-differentiated C1300 cells: 2ME exposure determined a 
similar decreased in α–tubulin expression in 0.1 and 1µM 2ME-
exposed cells (%C= 85 ±0.5 and %C= 82±0.7). Down-regulation of 
protein levels was more evident in 5µM 2ME-treated cells where 
values fell up to %C= 61 ±2.3 (Fig. 30).  
 
Acetylated α-tubulin 
Tapsigargin-differentiated C6 cells: when compared with control, 
acetylated α–tubulin levels were up-regulated in 0.1µM (%C= 90 
±0.8), 5µM (%C= 95±2.5) and mainly 1µM (%C= 100±1.5) 2ME-
exposed cells (Fig. 31).  
db-cAMP-differentiated C1300 cells: 2ME treatment upregulated 
acetylated α–tubulin expression since protein levels increased in 0.1 
µM (%C= 87±1.2), 5µM (%C= 96±3.2) and mainly in 1µM (%C= 





Tapsigargin-differentiated C6 cells: 2ME slightly downregulated 
protein expression in 0.1 and 1µM 2ME treated cells (%C= 95 ±2.2 
and %C= 90±2.7). Levels of protein declined as far as %C =74±0.9 
in 5µM 2ME-exposed cells (Fig. 33).  
db-cAMP-differentiated C1300 cells: a slight decrease in tyrosinated 
α–tubulin expression was ascertained in 0.1µM exposed cells (%C= 
93±2.7). Down-regulation was more marked in 1µM and mostly in 
5µM exposed cells in which values were %C= 80±1.2 and %C= 














                                                                                             
 
     
 
Fig. 13. Morphology of undifferentiated C6 cells after 2ME-exposure. Cells were cultured with 
RPMI-1640 medium containing 10% DCC-stripped serum. Cells were exposed to different 2ME 
micromolar concentrations (0.01, 0.1, 1, 5 and 10µM for 5 days) and viewed by contrast phase 
microscope at 20X. Control cells (ctrl), 0.01 and 0.1µM 2ME-exposed cells were confluent and 
uniform in size. If compared with control cells, 1µM 2ME-treated cells were reduced in number 
(about 30%), whereas 5 and 10µM 2ME-exposed cells displayed morphological alterations, such as 
flatness, globular shape and presence of cytoplasmic vacuoles. In addition, most cells were detached 






      
 
        
 
     
 
Fig. 14. Alterations in nuclear morphology of undifferentiated C6 cells induced by 2ME. Cells were 
cultured in RPMI-1640 medium containing 10% DCC-stripped serum. Cells were exposed to different 
2ME micromolar concentrations (0.01, 0.1, 1, 5 and 10µM for 5 days), stained with Hoechst 
33258/propidium iodide and finally viewed using a fluorescence microscope with a broad band filter 
(excitation wave length 365 nm) at 20X. Control cells (ctrl), 0.01 and 0.1µΜ 2ME-treated cells had 
single nuclei and were stained in blue by Hoechst dye, i.e. were viable. In 1, 5µΜ and mostly in 
10µΜ  2ME-exposed monolayers, dead cells (about 30% at 1µΜ,  60% at 5µΜ and 100% at 10µΜ), 






   
 
   
 
   
 
Fig. 15. Morphology of undifferentiated C1300 cell line after 2ME-exposure. Cells were cultured with 
RPMI-1640 medium containing 10% DCC-stripped serum. Cells were exposed to different 2ME 
micromolar concentrations (0.01, 0.1, 1, 5 and 10µM for 5 days) and viewed by contrast phase 
microscope at 20X. Control (ctrl) cells were confluent at 90% and uniform in size; starting from 
0.01 µM, cells were flat and shrunk  and reduction in number (10% approximately) was ascertained. 
Reduction in number was more remarkable at 0.1µM (30% approximately) and mainly in 1µM 2ME-
treated cells. 5 and 10µM a significant proportion of cells appeared detached from the dishes, exhibited 






     
 
     
 
    
 
Fig. 16. Alterations in nuclear morphology of undifferentiated C1300 cells induced by 2ME. Cells were 
cultured in RPMI-1640 medium containing 10% DCC-stripped serum. Cells were exposed to different 
2ME micromolar concentrations (0.01, 0.1, 1, 5 and 10µM for 5 days), stained with Hoechst 
33258/propidium iodide and finally viewed using a fluorescence microscope with a broad band filter 
(excitation wave length 365 nm) at 20X. Control cells (ctrl) had oval, homogeneous nuclei and did not 
display nuclear changes. About 20-40% of 0.01, 0.1 and 1µΜ 2ME-exposed cells showed the PI red 
staining and morphological features characteristic of cell death. The percentage of dead cells was greater 



























































Fig.17. Evaluation of number of viable cells (MTT test) in undifferentiated C6 and C1300 cell lines. 
Cells were plated in 96-well plates containing 50x103 cells in 200µl RPMI-1640 containing       
10% DCC-stripped serum and then exposed to different 2ME micromolar concentration (0.01, 0.1, 
1, 5 and 10µM for 5 days). Then, cells were incubated in 3-(4,5-dimethilthiazolyl-2)-2,5-
diphenyltetrazolium bromide assay (MTT, Cell Titer® 96) for 1h. MTT was bioreduced by living 
cells into a coloured formazan product that is soluble in tissue culture medium. Absorption values 
were read setting the automatic microtiter reader at 492nm (Uniskan II). This method correlates 
absorbance reading to the number of living cells. Undifferentiated C6 cells (left) showed since 
1µΜ concentration a gradual dose-dependent decrease (from -15% to -70%) in growth rate, when 
growth rate was fixed at 100% in control cells.  Interestingly, 0.01µΜ and 0.1µΜ 2ΜΕ−exposure 
increased growth rate which was approximately +5% , +10%. When compared to control cells, 
undifferentiated C1300 cells (right) were sensitive to 2ME in a marked dose-dependent manner: 
starting from 0.01µΜ a dramatic growth rate decline (from -30 to -90%) was ascertained.  
*P<0.05, **P<0.001 (Student’s t test) vs control cells (ctrl).  
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Fig. 18. Effect of 2ME on total α–tubulin expression in 
undifferentiated C1300 cells. Representative Western blot 
band, histogram and values of densitometric analysis of the 
bands. The blot is representative from four experiments and 
%C values (SEM) represent the mean values of four different 
experiments. Data are expressed as mean ±SEM (n=4), 
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Fig. 19. Effect of 2ME on total α–tubulin expression in 
undifferentiated C6 cells. Representative Western blot band, 
histogram and values of densitometric analysis of the bands. 
The blot is representative from four experiments and %C 
values (SEM) represent the mean values of four different 
experiments. Data are expressed as mean ±SEM (n=4), 
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Fig. 20. Effect of 2ME on acetylated α–tubulin expression in 
undifferentiated C6 cells. Representative Western blot band, 
histogram and values of densitometric analysis of the bands. 
The blot is representative from four experiments and %C 
values (SEM) represent the mean values of four different 
experiments. Data are expressed as mean ±SEM (n=4), 
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Fig. 21. Effect of 2ME on acetylated α–tubulin expression in 
undifferentiated C1300 cells. Representative Western blot 
band, histogram and values of densitometric analysis of the 
bands. The blot is representative from four experiments and 
%C values (SEM) represent the mean values of four different 
experiments. Data are expressed as mean ±SEM (n=4), 
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Fig. 22. Effect of 2ME on tyrosinated α–tubulin expression in 
undifferentiated C6 cells. Representative Western blot band, 
histogram and values of densitometric analysis of the bands.  The 
blot is representative from four experiments and %C values (SEM) 
represent the mean values of four different experiments. Data are 
expressed as mean ±SEM (n=4), *P=0.05, **P=0.01, (Student’s t 
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Fig. 23. Effect of 2ME on tyrosinated α–tubulin expression 
in undifferentiated C1300 cells. Representative Western 
blot band, histogram and values of densitometric analysis of 
the bands. The blot is representative from four experiments 
and %C values (SEM) represent the mean values of four 
different experiments. Data are expressed as mean ±SEM 




                                                                                                
     
 
 
      
 
Fig. 24. Morphology of tapsigargin-differentiated C6 cells after 2ME-treatment. Undifferentiated C6 cells 
were exposed to 4µM tapsigargin diluted in RPMI-1640 medium containing 10% DCC-stripped serum for 
five days, then cells were treated with different 2ME micromolar concentrations (0.1, 1, 5µM for 5 days) and 
viewed by contrast phase microscope at 20X. Control cells (ctrl) were confluent at 50% approximately with 
hypertrophic cell bodies and cytoplasmic processes up to ±70µm long. After 2ME treatment a reduction in 
number was ascertained. At 1µM some cells appeared shrunk and rounded, whereas 5µM 2ME-treated cells 



















    
                                                                                                 
   
 
Fig. 25. Morphology of tapsigargin-differentiated C6 cell line after 2ME-treatment. Undifferentiated 
C6 cells were exposed to 4µM tapsigargin with RPMI-1640 medium containing DCC 10% serum, then 
treated for 5 days with 2ME micromolar concentrations (0.1, 1, 5µM for 5 days), stained with Hoechst 
33258/propidium iodide and finally viewed using a fluorescence microscope with a broad band filter 
(excitation wave length 365nm). Control cells (ctrl) and 0.1µM 2ME-treated cells had single nuclei 
and they did not display nuclear alterations. In 1 and 5µM exposed-monolayers dead cells (red nuclei) 























    
 
Fig. 26. Morphology of db-cAMP-differentiated C1300 cell line after 2ME-treatment. 
Undifferentiated C1300 cells were exposed to 10 µM db-cAMP with RPMI-1640 medium containing 
10% DCC-stripped serum for five days, then cells were treated with different 2ME micromolar 
concentrations (0.1, 1, 5µM for 5 days) and viewed by contrast phase microscope at 20X. Control 
cells (ctrl) were uniform in size with a polygonal shape and long cytoplasmic processes. 2ME-
treatment determined a reduction in cell number; at 1µM and in a greater extent at 5µM some cells 







    
 
    
 
Fig. 27. Morphology of db-cAMP-differentiated C1300 after 2ME-treatment. Undifferentiated C1300 
were exposed to 10 µM db-cAMP with RPMI medium containing DCC 10% serum, then exposed to 
different 2ME micromolar concentrations (0.1, 1 and 5µM for 5 days), stained with Hoechst 
33258/propidium iodide and finally viewed using a fluorescence microscope with a broad band filter 
(excitation wave length 365nm). The nuclei of control cells and 0.1 µM 2ME-treated cells were stained 
in blue by Hoechst dye, i.e. viable. In 1 and 5µM 2ME exposed-monolayers, a great deal of cells (red 




























































Fig. 28. Evaluation of number of viable cells (MTT test) in tapsigargin-differentiated C6 and db-
cAMP-differentiated cell lines. Undifferentiated C6 and C1300 cells were plated in 96-well plates 
containing 50x103 cells in 200µl RPMI-1640 medium with 10% DCC serum. C6 and C1300 cells 
were exposed for 5 days to 4µM tapsigargin and 10µM db-cAMP respectively. Then, cells were 
treated with different 2ME micromolar concentration (0.1, 1 and 5µM for 5 days). Finally cells 
were incubated in 3-(4,5-dimethilthiazolyl-2)-2,5-diphenyltetrazolium bromide assay (MTT, Cell 
Titer® 96) for 1h. MTT was bioreduced by living cells into a colored formazan product that is 
soluble in tissue culture medium. Absorption values were read setting the automatic microtiter 
reader at 492nm (Uniskan II). This method correlates absorbance reading to the number of living 
cells. Tapsigargin-differentiated C6 cells (left) showed a decrease in the number of viable cells (-
20%) in 0.1µM 2ME exposed cells, when growth rate was fixed at 100% in control cells. At 1 and 
5µM the drop of the growth rate was more remarkable (-80%). db-cAMP-differentiated C1300 cells 
(right) appeared more sensitive than tapsigargin-differentiated C6 cells since the growth rate at 
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Fig. 29. Effect of 2ME on total α–tubulin expression in 
tapsigargin-differentiated C6 cells. Representative Western 
blot band, histogram and values of densitometric analysis of 
the bands. The blot is representative from four experiments. 
The %C values (SEM) represent the mean values of four 
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Fig. 30. Effect of 2ME on total α–tubulin expression in db-
cAMP differentiated C1300 cells. Representative Western blot 
band, histogram and values of densitometric analysis of the 
band. The blot is representative from four experiments. The %C 
values (SEM) represent the mean values of four different 
experiments. Data are expressed as mean ±SEM (n=4), 
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Fig. 31. Effect of 2-ME on acetylated α–tubulin expression in 
tapsigargin-differentiated C6 cells. Representative Western 
blot band, histogram and values of densitometric analysis of 
the bands. The blot is representative from four experiments. 
The %C values represent the mean values of four different 
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Fig. 32. Effect of 2ME on acetylated α–tubulin expression in 
db-cAMP differentiated C1300 cells. Representative Western 
blot band, histogram and values of densitometric analysis of the 
bands. The %C values (SEM) represent the mean values of four 
different experiments. Data are expressed as mean ±SEM (n=4), 
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Fig. 33. Effect of 2ME on tyrosinated α–tubulin expression in   
tapsigargin-differentiated C6 cells. Representative Western blot 
band, histogram and values of densitometric analysis of the bands. 
The %C values (SEM) represent the mean values of four different 
experiments. Data are expressed as mean ±SEM (n=4), *P=0.05, 
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Fig. 34. Effect of 2ME on tyrosinated α–tubulin expression in db-
cAMP differentiated C1300 cells. Representative Western blot 
band, histogram and values of densitometric analysis of the bands. 
The blot is representative from four experiments. The %C values 
(SEM) represent the mean values of four different experiments. 
Data are expressed as mean ±SEM (n=4), *P=0.05, (Student’s t 






































With the present study we evaluated the 2ME relative effectiveness 
in undifferentiated C6 & C1300 cells and in tapsigargin-
differentiated C6 & db-cAMP-differentiated C1300 cells. Our 
findings present new evidences about 2ME peculiar toxicity on glial 
and neuronal origin cell lines and contribute to the knowledge of 
general 2ME mechanisms of action in vitro.  
2ME cytotoxic and antiproliferative activities both in glial and 
neuronal origin cell lines were ascertained in agreement with 
literature reports (Nagakawa-Yagi et al., 1996; Kumar et al., 2003; 
Lis et al., 2004; Chamaon et. al., 2005 and Braeuninger et al., 2005). 
However, significant differences in relative the 2ME sensitiveness 
related to cell phenotype and differentiated or undifferentiated 
cellular status were ascertained. Indeed, IC501 values were α 0.01-
0.1µM and α 1-5µM for undifferentiated C1300 and C6 cells 
respectively, whereas they were ±0.1 and α 0.1-1µM for db-cAMP-
differentiated C1300 and tapsigargin-differentiated C6 cells in that 
order. Those results are in good accordance with microscopic 
examinations, viability tests and proliferation assays. 
Secondly, 2ME was confirmed causing alteration of tubulin 
expression in glial and neuronal cells origin as previously reported 
by Gokmen-Polar and co-workers (Gokmen-Polar et al., 2005). 
Modification of total α-tubulin, acetylated and tyrosinated α-
tubulin expression were related to the cell phenotypes and 
undifferentiated or differentiated cell status as above assessed. 2ME 
induced a dose-dependent reduction of tubulin expression both in 
undifferentiated C6 & C1300 cells.  
 
_____________________ 
1IC50 is the concentration of 2ME that is necessary to kill 50% of cells 
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Indeed, 2ME EC50/mg total protein2 values of total α-tubulin, acetylated 
and tyrosinated α-tubulin were >10µM, ≥10µM and α 5-10µM 
respectively for undifferentiated C6 cells, whereas EC50/ mg total protein 
values were α 0.1-1µM, ≥5µM and ±1µM in that order for 
undifferentiated C1300 cells. As it is well-known, modification of 
the tubulin expression and especially the alteration of tyrosinated α-
tubulin3 supports altered dynamic status of the microtubules. Every 
perturbation of tubulin dynamics leads to mitosis block and, as 
consequence, cell death (Brueggemeier et al., 2001). The extreme 
sensitiveness of undifferentiated C1300 cells to 2ME may be 
related to the relevant decrease in tubulin expression and marked 
down-regulation of tyrosinated α-tubulin. 
By contrast, alterations of tubulin expression were almost negligible 
in tapsigargin-differentiated C6 & db-cAMP-differentiated C1300 
cells. 2ME determined a slight dose-dependent down-regulation of 
total α-tubulin and tyrosinated α-tubulin (higher in C1300 cells 
than in C6 cells), whereas 2ME up-regulated acetylated α-tubulin 
expression (more markedly in C6 than in C1300 cells). Acetylated 
α-tubulin4 up-regulation and tyrosinated α-tubulin decrease 
demonstrate microtubular stabilization since analogous tubulin 
isoforms expression were ascertained in neurons treated with 
nocodazole, a potent microtubular stabilizing drug (Popoli et al., 
2000).  
_____________________ 
2 The concentration of 2ME which induces 50% reduction of the total protein amount 
(express in mg) of tubulin isoforms. 
 
3 Post-translational modification of α-tubulin associated with dynamic microtubular 
structures (Cumming  et al., 1984). 
4 Post-translational modification of α-tubulin associated with stable microtubules 
(Sasse et al., 1988). 
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Hence, 2ME-resistance of undifferentiated cells may be due to their 
microtubular stability. High microtubular stability of tapsigargin-
differentiated C6 cells may also explain higher 2ME-resistance in 
comparison with db-cAMP-differentiated C1300 cells. To 
summarize, our data show that: 
• Undifferentiated C6 & C1300 cells are more sensitive to 
2ME than tapsigargin-differentiated C6 & db-cAMP-differentiated 
C1300 cells; 
• 2ME is more effective in C1300 than in C6 cells 
independently from the undifferentiated/differentiated status. 
The first point agrees with the assumption that 2ME cellular 
sensitiveness is related to the cell proliferation rate5 (Lis et al., 2004 
and Kamath et al., 2006). 2ME is extremely effective in 
undifferentiated cells since they have a high proliferation rate. On 
the other hand, relative 2ME-resistance of differentiated cells is in 
good accordance with their low proliferation rate6. The following 
mechanisms of action may support this theory: 
 
2ME alters tubulin dynamics more intensively in high-
proliferating cells than in slow-proliferating cells 
As it is  well known 2ME  alters  tubulin  dynamics  by  its  binding  
 
___________________ 
5 The proliferation rate, a measure for the proliferation status of a cell population, is 
defined as the ratio between the number of cells in mitosis and the total number of 
cells. The proliferation rate is high in actively dividing cells (i.e. tumoural cells) while 
it is low in non actively dividing cells (i.e. fibroblasts). 
 
6 The proliferation rate of undifferentiated C6 & C1300 cells is ±15 times higher than 




ability to colchicine site (RJ D'Amato et al., 1994; Cushman et 
al.,1995 and Hamel et al., 1996). 2ME modifies microtubular 
dynamics stopping microtubule growth parameters, increasing the 
time of steady-state and interfering with chromosome progression 
or cell division (Seegers et al., 1997; Attalla et al., 1996; 
Brueggemeier et al., 2001; Tinley et al., 2003 and Kamath et al., 
2006). Thus, the intense proliferative and microtubular activity 
render high-proliferating cells (undifferentiated) much more 
susceptible than slow-proliferating cells (differerentiated) to the 
alterations of tubulin dynamics. Our results confirm that the marked 
2ME-induced alterations of tubulin dynamics are linked to relevant 
modification of cell physiology and cell morphology. 
 
2ME may induce apoptosis in high-proliferating cells  
2ME may induce apoptosis in high-proliferating cells such as 
tumoral cells (Seegers et al., 1997; Attalla et al., 1998; Huang et 
al., 2003, Shimada et al., 2003 and Bu et al., 2006). By contrast, 
2ME apoptotic activity has not been demonstrated in slow-
proliferating cells such as normal cells (Seegers et al., 1997). 
Several evidences suggest that 2ME can trigger apoptosis by 
activation of cell surface receptors. 2ME increases the expression 
of death receptors 5 (DR5) (La Valle et al., 2004), up-regulates p53 
(Seegers et al., 1997 and Shimada et al., 2003) or activates various 
MAP kinases (Attalla et al.,1998, Shimada et al., 2003 and Bu et 
al., 2006). 
2ME may indirectly induce apoptosis through the inhibition of the 
superoxide dismutases (SODs) as well. Accumulation of     cellular  
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O2- causes mitochondrial damages resulting in sequential cascade 
reactions which initiates apoptosis. Since high-proliferating cells 
have a more intense O2- production and a weaker SODs activity 
than slow-proliferating cells, high-proliferating cells are more 
responsive to any SODs perturbation than slow-proliferating cells 
(Huang et al, 2003). 
The second point apparently disagrees with previous assumptions. 
Indeed, though C6 cells are more proliferating than C13007 cells 
independently from the undifferentiated/differentiated status, we 
demonstrated that 2ME was more effective in C1300 cells than in 
C6 cells. However, the following hypothesis may clarify the 
apparent contradiction: 
 
Alteration of microtubule dynamics is more intense in C1300 
phenotype than in C6 phenotype  
The marked down-regulation of tubulin isoforms proves higher 
alteration of microtubule dynamics in C1300 phenotype than in C6 
phenotype. We hypothesize that the alteration of microtubule 
dynamics is more marked in neuronal cells not only because they 
express a greater pattern of α and β tubulin isoforms than glial 
cells, but also because 2ME has more affinity for neuronal α and β 
tubulin isoforms (Moura Neto et al., 1983).  
 
2ME induces metabolic failure and consequent excitotoxicity 
more intensely in C1300 than in C6 cells 




 C6 cells display a proliferation rate ±6 times higher than C1300 cells.  
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than in glial cells resulting in excitotoxicity8 phenomena.  Neuronal 
and glial sensitiveness to excitoxicity comes from peculiar neuronal 
and glial physiological properties.  
Neurons, and especially activate neurons, have a higher energy 
demand than glial cells. Since neurons only produce glutamate9 and 
they need higher amounts of glucose and lactate more than glial 
cells, if glucose and lactate are in short supply, neurons more likely 
than glial cells starve. Thus, any metabolic failure determines 
cellular damages greater in neuronal than in glial cells. As pointed 
out on retinoic acid-differentiated human neuroblastoma cells 
(Nakagawa-Yagi et al., 1996), we hypothesized that 2ME causes 
metabolic perturbations resulting in energy depletion higher in 
C1300 than in C6 cells. Consequence of any energetic depletion is 
immediate failure of Na+/K+ pumps with depolarization of cellular 
membranes and immediate breakdown of cellular functions. In 
neuronal cells depolymerization of membranes arrests the synaptic 
function and neuronal conductivity inducing the release of 
disproportionate amounts of glutamate in the synaptic cleft 
(excitotoxicity). Though glutamate is indispensable for numerous 
neuronal functions, excessive quantities released in the synaptic cleft 
could act as neuronal poison. Glutamate activates some specific 
receptors   that  are   non-selective  cation-permeable ion channels. 
Over-activation of these receptors causes an excessive passive influx 
of  Cl- and Na+ into cells  that  determines an  osmotic  failure  and  
 
____________________ 
8 Excitotoxicity, by definition, is a typical neuronal cytotoxic phenomenon following the 
over-activation of glutamate receptors determined by the excessive release of glutamate  
amounts in the synaptic cleft. 
9 The most common excitatory neurotransmitter. 
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resultant cell death within few minutes. In addition, abnormal 
glutamate release may also lead to an anomalous Ca++10 influx into 
neurons which effect structural damages of neuronal cells after hours 
or days. Indeed, over-activation of some glutamate receptors that are 
permeable to Ca++ causes massive influx of this cation that, by 
consequence, activates several catabolic enzymes (i.e. proteases, 
phospholipases and endonucleases) and nitric oxide (NO) syntethase, 
with following formation of the free radical NO. Free radicals and 
activated catabolic enzymes destroy structural proteins, membrane 
lipids, nucleic acids and other cellular contents, causing neuronal 
necrosis and triggering cellular apoptosis (Dirnagl et al., 1999 and 
MacDonald et al., 2006). 
To summarize, excitotoxicity involves in a lesser extent glial cells 
because: a) glial cells are less sensitive to any metabolic failure as 
they have metabolic demands lower than neuronal cells b) glial 
cells have a lower number of voltage-gated channel than neuronal 
cells and, by consequence, are not excitable and are not susceptible 
to any over-activation of glutamate receptors.  
Elucidating the differences in sensitiveness between 
undifferentiated/differentiated C6/C1300 cells is important for 
understanding mechanisms of 2ME action and  to provide 
information for analogue in vivo/in vitro studies.  
This study supports the assumption that 2ME toxicity is a 
phenomenon  involving  multifactorial  mechanisms. We  believe 
 
______________________________________ 
10 α-amino-3hydroxy-5-methyl-4-isoxazolepropionic receptors (AMPA) and glutamate 
N methyl-D-aspartate receptors (NMDA).  
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that 2ME cytotoxic action is mainly due to the synergic 
perturbation of microtubular dynamics and the metabolic patterns 
rather than the possible indirect induction of apoptosis (SODs 
inhibition, up-regulation of p53 and activation of various kinases). 
Our study confirms the pivotal role of cytoskeleton in cytotoxicity 
2ME-induced phenomena. We clearly demonstrate that specific 
cytoskeletal/metabolic patterns are strictly linked with different rate 
of tubulin dynamics alteration and, as consequence, with relative 
2ME effectiveness in cell populations. On the other hand, we 
believe that a crucial point to better understand 2ME mechanisms 
of action is the identification of the signaling pathways that link the 
ability of 2ME to alter tubulin dynamics and to induce apoptosis.  
In conclusion, our findings may support further study on in vitro 
glial and neuronal 2ME-exposed cells aimed at determining the 
correlation between the alteration of tubulin dynamics and the 
initiation of apoptosis. Comprehension of 2ME mechanisms of 
action can be crucial for the study of the pathogenesis and the 
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